<DOC>
	<DOCNO>NCT02881320</DOCNO>
	<brief_summary>The primary objective study evaluate steady state pharmacokinetics ( PK ) bictegravir ( GS-9883 ) confirm dose bictegravir/emtricitabine/tenofovir alafenamide ( B/F/TAF ) fixed-dose combination ( FDC ) HIV-1 infect , virologically suppress adolescent ( 12 &lt; 18 year age ) child ( 6 &lt; 12 year age ) . This study also evaluate safety tolerability B/F/TAF FDC Week 24 HIV-1 infect , virologically suppress adolescent child .</brief_summary>
	<brief_title>B/F/TAF FDC HIV-1 Infected Virologically Suppressed Adolescents Children</brief_title>
	<detailed_description />
	<criteria>Key HIV1 infect adolescent child virologically suppress ≥ 6 month stable regimen Cohort 1 : 12 &lt; 18 year old weight screen ≥ 35 kg ( 77 lb ) Cohort 2 : 6 &lt; 12 year old weight screen ≥ 25 kg ( 55 lb ) Documented plasma HIV1 RNA &lt; 50 copies/mL stable regimen ( undetectable HIV1 RNA level accord local assay use limit detection ≥ 50 copies/mL ) ≥ 6 month precede Screening visit . Unconfirmed virologic elevation ≥ 50 copies/mL ( transient detectable viremia , `` blip '' ) prior screen acceptable . If low limit detection local HIV1 RNA assay &lt; 50 copies/mL ( eg , &lt; 20 copies/mL ) , plasma HIV1 RNA level exceed 50 copies/mL two consecutive HIV1 RNA test . Stable antiretroviral regimen 2 nucleoside reverse transcriptase inhibitor ( NRTIs ) combination third agent minimum 6 month prior screen visit . Individuals undergo dose modification antiretroviral regimen growth switch medication formulation ( ) consider stable antiretroviral regimen . Estimated glomerular filtration rate ( GFR ) ≥ 90 mL/min/1.73 m^2 accord Schwartz Formula No document suspect resistance emtricitabine ( FTC ) , tenofovir ( TFV ) , integrase strand transfer inhibitor ( INSTIs ) include , limited , reverse transcriptase resistance mutation K65R M184V/I Note : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>